Earnings History Data for 89BIO (ETNB) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

89BIO

89bio Inc. is clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, BIO89-100, is being developed for the treatment of nonalcoholic steatohepatitis. 89bio Inc. is headquartered in San Francisco.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
11-11-2021 AH ETNB 89BIO 359.00 -1.41 -1.07 0.00 89bio EPS misses by $0.35
[11/11/2021 4:25 PM]
17.65 -0.24 
(-1.37%)
17.89 0.0 
(0.00%)
14.70 - 28.28 43,262 70,000 201
12-05-2021 AH ETNB 89bio, Inc. 484.24 -0.74 -0.67 -0.76 89bio EPS misses by $0.04
[5/12/2021 4:48 PM]
20.33 -3.08 
(-13.16%)
23.41 0.0 
(0.00%)
18.01 - 42.36 169,873 60,000 443
24-03-2021 AH ETNB 89bio, Inc. 531.36 -0.63 -0.90 -2.58 89bio EPS beats by $0.25
[3/24/2021 4:52 PM]
23.48 1.69 
(7.77%)
21.79 0.0 
(0.00%)
18.01 - 42.36 168,937 120,000 445
10-11-2020 AH ETNB 89bio, Inc. 416.00 -0.86 -0.89 0.00 89bio EPS beats by $1.73
[11/10/2020 4:38 PM]
25.04 0.74 
(3.05%)
24.30 0.0 
(0.00%)
14.00 - 47.25 260,495 171,653 392